Temomaps 100mg Capsule

About

Temozolomide is an oral alkylating agent primarily used in the treatment of certain brain tumors. It functions by interfering with the DNA of cancer cells, preventing their growth and division, ultimately leading to cell death. This cytotoxic effect is particularly valuable in rapidly dividing cells, such as those found in aggressive gliomas. As a prodrug, it is spontaneously hydrolyzed at physiological pH to its active compound, MTIC (5-(3-methyl-1-triazen-1-yl)imidazole-4-carboxamide). Temozolomide's ability to cross the blood-brain barrier makes it an effective option for central nervous system malignancies. It is often utilized in combination with radiation therapy or as a monotherapy, depending on the specific tumor type and stage. Its mechanism targets DNA replication and transcription, making it a cornerstone in the management of glioblastoma multiforme and anaplastic astrocytoma.

Uses

• Treatment of newly diagnosed glioblastoma multiforme.
• Treatment of refractory anaplastic astrocytoma.
• Management of other high-grade gliomas.
• Used in combination with radiation therapy.

Directions For Use

Take the capsule orally on an empty stomach, preferably at bedtime, as directed by your doctor. Swallow whole with water; do not open, crush, or chew.

Benefits

• Effective in treating certain aggressive brain tumors.
• Can prolong survival in glioblastoma patients.
• Oral administration offers convenience for patients.
• Can be used in combination with radiation therapy.
• Helps to control tumor growth and progression.
• Improves disease-free survival in specific indications.

Side Effects

• Nausea and vomiting
• Fatigue
• Headache
• Constipation
• Loss of appetite
• Hair loss (alopecia)
• Myelosuppression (low blood counts)
• Thrombocytopenia (low platelets)
• Neutropenia (low white blood cells)
• Rash
• Dizziness
• Infection risk

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may exacerbate side effects like nausea and fatigue, and potentially increase liver strain.
• Pregnancy - Temozolomide is contraindicated in pregnancy due to potential fetal harm. Effective contraception is required during treatment and for a period after.
• Breastfeeding - Breastfeeding is not recommended during Temozolomide treatment and for a period after, as the drug may pass into breast milk and harm the infant.
• Liver - Use with caution in patients with severe hepatic impairment. Liver function should be monitored regularly during treatment.
• Kidney - Use with caution in patients with severe renal impairment. Dosage adjustments may be necessary based on kidney function.
• Lung - Rarely, interstitial pneumonitis or pulmonary fibrosis can occur. Report any new or worsening respiratory symptoms to your doctor.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.